We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich Ire1alpha Inhibitor, Mkc-3
List Price $214.60 Your Price $214.60
Sigma-Aldrich Ire1alpha Inhibitor, Mkc-3946 - Calbiochem; 1ea; >=97% (HPLC) - SIAL (Additional S&H Or Hazmat Fees May Apply)
NETA PART: SIAL-5327580001
MFG.PART: 5327580001
UNSPSC: 41115709
Manufacturer: Sigma-Aldrich


Assay
≥97% (HPLC)
Quality Level
100
Form
powder
Manufacturer/Tradename
Calbiochem®
Storage Condition
OK to freeze
protect from light
Color
dark yellow
Solubility
DMSO: 25 mg/mL
Storage Temp.
−20°C
General Description
A cell-permeable compound that binds to the endoribnuclease domain of IRE1α and inhibits its activity. Blocks XBP1 mRNA splicing in RPMI 8226 human multiple myeloma cells.A cell-permeable naphthaldehyde derived compound that binds to the endoribnuclease domain of inositol requiring enzyme1α (IRE1α) to inhibit its activity and blocks X-box binding protein 1 (XBP1) mRNA splicing in RPMI 8226 human multiple myeloma (mm) cells. Down-regulates SEC61A1, p58IPK, and ERdj4 genes that are targeted by XBP1. Also shown to block XBP1s expression induced by tunicamycin without affecting the phosphorylation of IRE1a (50 mg/kg, i.p). Shown to enhance bortezomib (Cat. No. 504314) and 17-AAG (Cat. No, 100068) induced toxicity and apoptosis in RPMI8226 and INA6 cells. However, it does not have any significant effect on normal mononuclear cells. Suppresses the growth of RPMI 8226 xenografts in a model of human mm in mice (50 mg/kg, i.p.).A cell-permeable naphthaldehyde derived compound that binds to the endoribnuclease domain of inositol requiring enzyme1α (IRE1α) to inhibit its activity and blocks X-box binding protein 1 (XBP1) mRNA splicing in RPMI 8226 human multiple myeloma (mm) cells. Down-regulates SEC61A1, p58IPK, and ERdj4 genes that are targeted by XBP1. Also shown to block XBP1s expression induced by tunicamycin without affecting the phosphorylation of IRE1a (50 mg/kg, i.p). Shown to enhance bortezomib (Cat. No. 504314) and 17-AAG (Cat. No, 100068) induced toxicity and apoptosis in RPMI8226 and INA6 cells. However, it does not have any significant effect on normal mononuclear cells. Suppresses the growth of RPMI 8226 xenografts in a model of human mm in mice (50 mg/kg, i.p.).Please note that the molecular weight for this compound is batch-specific due to variable water content.
Biochem/Physiol Actions
Cell permeable: yesPrimary TargetIRE1
Warning
Toxicity: Standard Handling (A)Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.Other Notes
Mimura, N., et Al. 2012.Blood. 119,5772.CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany| SKU | SIAL-5327580001 |
|---|---|
| Supplier Part Number | 5327580001 |
| UM | EA |
| UNSPSC | 41115709 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIAL |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 9 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |

